Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Overcoming Bcr-Abl T315I mutation by combination of GNF-2 and ATP competitors in an Abl-independent mechanism

  • Mamduh Khateb1,
  • Nili Ruimi1,
  • Hazem Khamisie1,
  • Yousef Najajreh2,
  • Afsar Mian3,
  • Anna Metodieva3,
  • Martin Ruthardt3 and
  • Jamal Mahajna1, 4Email author
BMC Cancer201212:563

DOI: 10.1186/1471-2407-12-563

Received: 27 March 2012

Accepted: 23 November 2012

Published: 27 November 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
27 Mar 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
13 Jun 2012 Reviewed Reviewer Report - Paolo Neviani
19 Jun 2012 Reviewed Reviewer Report - Jamshid Sorouri Khorashad
19 Jul 2012 Author responded Author comments - Jamal Mahajna
Resubmission - Version 6
19 Jul 2012 Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
Resubmission - Version 8
Submitted Manuscript version 8
Resubmission - Version 9
Submitted Manuscript version 9
Resubmission - Version 10
Submitted Manuscript version 10
24 Sep 2012 Reviewed Reviewer Report - Paolo Neviani
24 Sep 2012 Reviewed Reviewer Report - Jamshid Sorouri Khorashad
22 Oct 2012 Author responded Author comments - Jamal Mahajna
Resubmission - Version 11
22 Oct 2012 Submitted Manuscript version 11
12 Nov 2012 Reviewed Reviewer Report - Paolo Neviani
Resubmission - Version 12
Submitted Manuscript version 12
Publishing
23 Nov 2012 Editorially accepted
27 Nov 2012 Article published 10.1186/1471-2407-12-563

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Cancer Drug Discovery Program, Galilee Technology Center, Migal
(2)
Faculty of Pharmacy, Al-Quds University
(3)
Medizinische Klinik II/Abt. Hämatologie, Klinikum der Goethe-Universität
(4)
Department of Nutritional Sciences, Tel-Hai College

Advertisement